Population pharmacokinetics (PK) of nevirapine (NVP) in HIV-infected adults

被引：0
|
作者：
Schipani, A. [1 ]
Wakeham, K. [2 ,3 ]
Ggayi, A. [2 ]
Kamali, A. [2 ]
Lalloo, D. G. [3 ]
Youle, M. [4 ]
Johnson, M. [4 ]
Khoo, S. [1 ]
Dickinson, L. [1 ]
Back, D. [1 ]
机构：
[1] Univ Liverpool, Dept Pharmacol, Liverpool L69 3BX, Merseyside, England
[2] MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda
[3] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England
[4] Royal Free Hosp, Dept HIV Med, London NW3 2QG, England
来源：
HIV MEDICINE | 2009年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [41] Association of Human Leukocyte Antigen Alleles and Nevirapine Hypersensitivity in a Malawian HIV-Infected Population
    Carr, Daniel F.
    Chaponda, Mas
    Jorgensen, Andrea L.
    Castro, Elena Cornejo
    van Oosterhout, Joep J.
    Khoo, Saye H.
    Lalloo, David G.
    Heyderman, Robert S.
    Alfirevic, Ana
    Pirmohamed, Munir
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 56 (09) : 1330 - 1339
  • [42] Sex differences in nevirapine disposition in HIV-infected patients
    Regazzi, M
    Villani, P
    Seminari, E
    Ravasi, G
    Cusato, M
    Marubbi, F
    Meneghetti, G
    Maserati, R
    [J]. AIDS, 2003, 17 (16) : 2399 - 2400
  • [43] Nevirapine induced exfoliative dermatitis in an HIV-infected patient
    Bhandarkar, Anoosha P.
    Kop, Priydarshini B.
    Pai, Varadraj V.
    [J]. INDIAN JOURNAL OF PHARMACOLOGY, 2011, 43 (06): : 738 - U148
  • [44] Efavirenz to nevirapine switch in HIV-infected patients with dyslipidemia
    Blanco, Francisco
    [J]. AIDS REVIEWS, 2007, 9 (02) : 126 - 126
  • [45] Sertraline Pharmacokinetics in HIV-Infected and Uninfected Children, Adolescents, and Young Adults
    Hanan, Nathan John
    Paul, Mary Elizabeth
    Huo, Yanling
    Kapetanovic, Suad
    Smith, Elizabeth
    Siberry, George
    Brouwers, Pim
    Graham, Bobbie
    Johnston, Benjamin
    Capparelli, Edmund V.
    Best, Brookie M.
    [J]. FRONTIERS IN PEDIATRICS, 2019, 7
  • [46] Pharmacokinetics of nevirapine in HIV-infected children under 3 years on rifampicin-based antituberculosis treatment
    Oudijk, J. Mirjam
    McIlleron, Helen
    Mulenga, Veronica
    Chintu, Chifumbe
    Merry, Concepta
    Walker, A. Sarah
    Cook, Adrian
    Gibb, Diana M.
    Burger, David M.
    [J]. AIDS, 2012, 26 (12) : 1523 - 1528
  • [47] Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals
    Smith, PF
    DiCenzo, R
    Forrest, A
    Shelton, M
    Friedland, G
    Para, M
    Pollard, R
    Fischl, M
    DiFrancesco, R
    Morse, GD
    [J]. CLINICAL PHARMACOKINETICS, 2005, 44 (01) : 99 - 109
  • [48] Pharmacokinetics of nevirapine, stavudine and lamivudine in Indian HIV-infected children receiving generic fixed dose combinations
    Mukherjee, Aparna
    Singla, Mohit
    Velpandian, T.
    Sirohiwal, Anju
    Vajpayee, M.
    Singh, Ravinder
    Kabra, S. K.
    Lodha, Rakesh
    [J]. INDIAN PEDIATRICS, 2014, 51 (03) : 191 - 197
  • [49] Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women
    Dong, Betty J.
    Zheng, Yu
    Hughes, Michael D.
    Frymoyer, Adam
    Verotta, Davide
    Lizak, Patricia
    Sawe, Frederick
    Currier, Judith S.
    Lockman, Shahin
    Aweeka, Francesca T.
    [J]. AIDS, 2012, 26 (07) : 833 - 841
  • [50] Pharmacokinetics of nevirapine, stavudine and lamivudine in Indian HIV-infected children receiving generic fixed dose combinations
    Aparna Mukherjee
    Mohit Singla
    T. Velpandian
    Anju Sirohiwal
    M. Vajpayee
    Ravinder Singh
    S. K. Kabra
    Rakesh Lodha
    [J]. Indian Pediatrics, 2014, 51 : 191 - 197
12345